Cart
sales@molnova.com
ATG7-IN-1
CAS No. 2226229-87-2
ATG7-IN-1( —— )
Catalog No. M35143 CAS No. 2226229-87-2
ATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 758 | In Stock |
|
| 10MG | 1036 | In Stock |
|
| 25MG | 1568 | In Stock |
|
| 50MG | 2074 | In Stock |
|
| 100MG | 2725 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameATG7-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
-
DescriptionATG7-IN-1 is a selective ATG7 inhibitor with an IC50 of 62 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2226229-87-2
-
Formula Weight470.5
-
Molecular FormulaC17H19FN6O5S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(C=1C=2C(N(N1)[C@@H]3O[C@@H](COS(N)(=O)=O)[C@@H](O)C3)=NC=NC2N)C4=C(F)C=C(C)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GW406108X (b)
GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .
-
CA77.1
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).
-
MPP+ iodide
MPP+ iodide, the metabolite of a neurotoxin MPTP, causes symptom of Parkinson's disease (PD) in animal models by selectively destroying dopaminergic neurons in substantia nigra.
